Thursday, 26 July 2018

AstraZeneca joins U.S. drug price freeze for rest of 2018

AstraZeneca has joined other drugmakers in freezing prices in the United States for the rest of 2018, following criticism by U.S. President Donald Trump over the cost of medicine.


Posted by at

No comments:

Post a Comment

Subscribe to: Post Comments (Atom)